Earnings Call Summary | SNC-LAVALIN GROUP INC(SNCAF.US) Q1 2024 Earnings Conference
Earnings Call Summary | SNC-LAVALIN GROUP INC(SNCAF.US) Q1 2024 Earnings Conference
The following is a summary of the AtkinsRéalis (SNCAF) Q1 2024 Earnings Call Transcript:
以下是阿特金斯雷阿利斯（SNCAF）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
AtkinsRéalis reported a 19% increase in Q1 revenue with a 19.5% increase in segment-adjusted EBIT to approximately $187 million.
Operating cash flow improved considerably to $37 million, aligned with expectations of delivering over $400 million for the full year.
The company's backlog grew to $15 billion, marking a 26% growth YoY.
The net limited recourse and recourse debt to adjusted EBITDA ratio stood at 1.7 times, within their target range of 1.5 to 2 times.
阿特金斯雷阿利斯報告稱，第一季度收入增長了19％，經細分市場調整後的息稅前利潤增長了19.5％，達到約1.87億美元。
運營現金流大幅改善至3700萬美元，與全年交付超過4億美元的預期一致。
該公司的待辦事項增至150億美元，同比增長26％。
有限追索權和追索權債務淨額佔調整後息稅折舊攤銷前利潤比率爲1.7倍，在1.5至2倍的目標範圍內。
Business Progress:
業務進展：
AtkinsRéalis witnessed significant opportunities for growth in its core Engineering and Nuclear services.
Notable success was seen in Canada, the UK, Ireland, the US, Latin America, and the EMAE region, with substantial organic revenue growth in each market.
The company launched the Canadians for CANDU campaign, promoting the deployment of CANDU nuclear technology for emission reduction efforts.
The 'Pivoting to Growth' strategy saw implementation with a focus on organic growth across multiple geographies, particularly in nuclear and transport markets.
AtkinsRéalis is actively strategizing to attract and retain suitable talent for its nuclear division.
A plan to exit a global business (the Linx [ph]) is in progress, showcasing a strategic shift in business focus.
Atkinsréalis見證了其核心工程和核服務的重大增長機會。
加拿大、英國、愛爾蘭、美國、拉丁美洲和EMAE地區取得了顯著的成功，每個市場的有機收入均大幅增長。
該公司發起了 “加拿大人支持CANDU” 運動，促進CANDU核技術的部署，以減少排放。
“轉向增長” 戰略的實施重點是多個地區的有機增長，尤其是在覈能和運輸市場。
阿特金斯雷阿利斯正在積極制定戰略，爲其核部門吸引和留住合適的人才。
退出全球企業（Linx [ph]）的計劃正在進行中，這表明了業務重點的戰略轉移。
More details: SNC-LAVALIN GROUP INC IR
更多詳情： SNC-LAVALIN 集團公司
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。